MRNA Moderna is set for a pivotal FDA flu vaccine decision. The FDA will likely decide this week whether or not to approve Moderna’s experim
MRNA Moderna is set for a pivotal FDA flu vaccine decision. The FDA will likely decide this week whether or not to approve Moderna’s experimental mRNA influenza vaccine — potentially the first licensed flu shot based on mRNA technology - STAT News